Drug intelligence / Profile preview

technetium-99m-methylene diphosphonate

Development stage
Approved
Lead developer
Curium
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Technetium-99m-methylene diphosphonate is a radiopharmaceutical used primarily as a bone imaging agent in nuclear medicine. It consists of the gamma-emitting radionuclide technetium‑99m complexed with methylene diphosphonate (MDP), a bisphosphonate that binds to hydroxyapatite crystals in bone. After intravenous injection, it localizes to areas of increased osteogenesis or altered bone metabolism, allowing for detection and imaging of various bone pathologies using single photon emission computed tomography (SPECT). It is widely used for diagnosing conditions such as fractures, osteomyelitis, malignancies including bone metastases, and other disorders affecting skeletal turnover[2][4][5][9].

Brand names
CIS-MDPMPI MDPOsteolite
Other names
technetium Tc 99m medronatetechnetium (99mTc) medronic acidtechnetium methylene diphosphonate

Beyond the preview

Go deeper on technetium-99m-methylene diphosphonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium-99m-methylene diphosphonate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call